Article: DAMON SUCCUMBS TO NOMAD'S OFFER

Damon Corp. of Needham, which operates a network of medical laboratories, yesterday finally bowed to the aggressive suitor that has been pursuing the firm for 10 months.

In a deal called "just short of something hostile" by one analyst yesterday, Damon said it agreed to be acquired by Nomad Partners L.P., a New York investment firm formed specifically to buy Damon.

Nomad will pay $257 million, or $26 a share, in cash. Shareholders also will be entitled to 50 percent of the after-tax cash proceeds from the sale of Damon's interest in its Damon Biotech subsidiary, if the sale takes place between now and the merger consummation date expected in May.

"It was the right thing to do at ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!